The incidence of end-stage liver disease or cirrhosis continues to rise worldwide. (1) The only curative treatment for liver cirrhosis remains transplantation. As part of liver transplantation, the hepatic blood flow is temporarily interrupted to aid surgery, but this leads to the development of ischemia/reperfusion injury (IRI) once blood flow to the liver is restored. (2, 3) Moreover, 20% of the complications following liver transplantation, including graft dysfunction and/or primary graft nonfunction, are directly attributable to IRI. (4) IRI is a proinflammatory antigen-independent process that causes liver parenchymal cell injury. (4) Specifically, the first cell type to be injured by liver IRI are the liver endothelial cells (LEC). (5) However, the mechanisms that regulate injury to LEC during IRI BhOgal et al.
remain to be fully determined. It is known that reactive oxygen species (ROS) are key regulators of liver IRI. (2, 6) ROS can be generated by both parenchymal and nonparenchymal cells (eg, Kupffer cells) within the liver during IRI. (6, 7) Recent studies suggest ROS generated within liver parenchymal cells, such as LEC, may be integral to the development of liver IRI. (6) Importantly, ROS can have divergent effects upon cell survival with emerging evidence suggesting that ROS generation during early IRI is cytoprotective through its activation of the autophagy-signaling pathway. (8, 9) Autophagy is an evolutionarily conserved process that is regulated by a distinct cellular machinery known as the autophagy-related proteins (ATGs). Activation of autophagy allows cells to enclose targeted cargo in a double membrane structure known as an autophagosome during periods of cellular stress such as IRI. (10) Following sequential maturation steps that involve various ATGs, ATG8/LC3B and the docking protein p62 regulate the fusion of the autophagosome with lysosomes to form autophagolysomes with resultant cargo degradation. (11) The substrates from cargo breakdown are then available for anabolic cellular processes. (10) Recently, it has become apparent that the cargo targeted by autophagy can be highly selective, leading to the elimination of mitochondria (mitophagy), endoplasmic reticulum (ERphagy), and bacteria (xenophagy). (10) In particular, autophagy in LEC has recently been shown to be regulated by Kruppel-like factor 2 (KLF2). (12) These studies suggest that failure of this mechanism of autophagy activation can lead to endothelial cell death during periods of stress and is associated with microvascular dysfunction, a key feature of liver IRI. (12) There is growing interest in the regulation of liver IRI by autophagy (9) particularly because ROS has been shown to regulate the autophagy-signaling pathway. (13) However, the role of both ROS and autophagy in LEC remains to be determined, although studies in cells of endothelial lineage such as human umbilical vein endothelial cell and vascular endothelium suggest that autophagy is cytoprotective during oxidative stress. (14, 15) Our study investigated the role of ROS and autophagy in determining primary human LEC function during IRI.
Materials and Methods

isOlatiOn anD cUltUre OF lec
Liver tissue was obtained via the Hepatobiliary and Liver Transplant Surgery program at the Queen Elizabeth Hospital Birmingham, Birmingham, United Kingdom, from fully consenting adult patients undergoing transplantation, hepatic resection for liver metastasis, hepatic resection for benign liver disease, or normal donor tissue surplus to surgical requirements. Ethical approval for the study was granted by the local research ethics committee (reference number 06/ Q702/61). LEC were isolated from human liver tissue as previously described. (16) Briefly, parenchymal cells were collected after collagenase digestion of mechanically disaggregated livers and were further purified by density gradient centrifugation over Percoll. Endothelial cells were isolated from the resultant heterogeneous cell mixture by positive immunomagnetic selection using antibodies raised against CD31 (Dako) and magnetic beads (Dynal, Santa Clara, CA) conjugated with goat anti-mouse antibody according to the manufacturer's protocol. All endothelial cells were maintained in complete media comprising Human Endothelial-SFM basal growth medium (Invitrogen, Carlsbad, CA) containing 104 U/mL penicillin and 10 μL/mL streptomycin, 10 ng/mL epidermal growth factor (R&D Systems, Minneapolis, MN), 10 ng/mL vascular endothelial growth factor, and 10% heat-inactivated human serum (TCS Biologicals, Buckinghamshire, UK). All endothelial cells were plated out into collagen-coated culture flasks (Sigma, St. Louis, Missouri) and maintained at
Original article | 1439 37°C in a humidified 5% CO 2 incubator until confluent. The endothelial cells were used for experiments only up to passage 6, and phenotypic identity and purity were confirmed by staining for endothelial markers as previously described. (16) This rigorous standardized protocol used to isolate primary human LEC is well accepted, has been shown to maintain the function and phenotype of LEC, and has been in longstanding use in our laboratory. (17) in vitrO MODel OF iri
In experiments, primary human LEC were cultured in the conditions described previously. LEC were used in an in vitro model of IRI that was previously described. (6, 8, 18) Hypoxia was achieved by placing cells in an airtight incubator (Don Whitley, Bingley, United Kingdom) flushed with 5% CO 2 and 95% N 2 until oxygen content in the chamber reached 0.1%, as verified by a dissolved oxygen monitor (DOH-247-KIT, Omega Engineering, Manchester, United Kingdom). Normoxia denotes LEC maintained in ambient oxygen conditions, hypoxia denotes LEC maintained at 0.1% oxygen for 24 hours, and hypoxia/reoxygenation (H-R) denotes LEC kept at 0.1% oxygen for 24 hours and then transferred to ambient oxygen conditions for a further 24 hours. In experiments involving N-acetylcysteine (NAC), the antioxidant was made fresh as a stock solution and added using the correct dilution factor to the relevant experimental wells. Vehicle-only wells were used as controls. NAC was added to LEC at the time of placement of cells into normoxia, hypoxia, or H-R.
DeterMinatiOn OF lec rOs prODUctiOn, apOptOsis, anD necrOsis
Primary human LEC ROS production, apoptosis, and necrosis during in vitro IRI was determined by using a 3-color reporter assay system that we have previously described. (6) Briefly, ROS accumulation was determined using the fluorescent probe 2′,7′-dichlorofluorescin-diacetate (DCF; Merck, 287810, Nottingham, United Kingdom). Apoptosis was determined by labeling cells with Annexin V (Molecular Probes, Invitrogen, A35122), and 7-amino-actinomycin D (7AAD; Molecular Probes, Invitrogen, A1310) was used to assess necrosis. For flow cytometry, at least 20,000 events were recorded within the gated region of the flow cytometer for each primary human LEC preparation in each experimental condition. Only the cells within the gated region were used to calculate mean fluorescence intensity (MFI).
transFectiOn OF atg7 sMall interFering rna in priMarY hUMan lec
Scrambled small interfering RNAs (siRNAs) and siRNAs for ATG7 were purchased from ThermoFisher Scientific (Leicester, United Kingdom). Primary human LEC were seeded in the wells of culture dishes. After 24 hours, the cells were transfected with 50 nmol/L scrambled siRNAs or 50 nmol/L ATG7 siRNA using the Lipofectamine RNAiMAX transfection reagent (Invitrogen) according to the manufacturer's protocol. Knockdown of ATG7 was confirmed with polymerase chain reaction (PCR) using standard primers. Following experiments, primary human LEC were fixed in ice-cold methanol followed by serial washing with phosphate-buffered saline (PBS). LEC were permeabilized in 0.1% Triton X-100 for 20 minutes at room temperature. LEC were then incubated in blocking buffer for 45 minutes. Cells were then incubated in primary rabbit anti-human LC3B antibodies (1:400, Cell Signaling Technology, Lieden, Netherlands) or control antibody for 2 hours at room temperature. After rinsing with PBS, LEC were incubated with donkey-anti-rabbit immunoglobulin G (IgG) Alexa Fluor 594 secondary antibody (1:2000; Molecular Probes, Eugene, OR) for 1 hour at room temperature. Cells were mounted with ProLong Gold antifade with 4´,6-diamidino-2-phenylindole (DAPI; Molecular Probes). Images were captured with a charge-coupled device (CCD) camera and imported into Adobe Photoshop, and LC3B puncta in cells were quantified using ImageJ software.
For dual immunofluorescence experiments following incubation with IgG Alexa Fluor 594 secondary antibody, LEC were washed with PBS and incubated at room temperature for 1 hour with mouse anti-human TOMM-20 antibodies (1:200, Abcam, Cambridge, United Kingdom). After rinsing with PBS, sections were incubated with goat anti-mouse IgG Alexa Fluor 488 secondary antibody (1:1000; Molecular Probes) for 1 hour at room temperature. Cells were mounted with ProLong Gold antifade with DAPI (Molecular Probes). Images were captured with a CCD camera and imported into Adobe Photoshop. LC3B puncta and TOMM-20 staining in cells were quantified using ImageJ software.
Western BlOtting
For Western immunoblotting studies, primary human LEC were lysed at the end of the relevant experimental period using Nonidet P40 lysis buffer: 20-mM trishydroxymethylaminomethane-HCl (pH 8; T3253, Sigma-Aldrich, St. Louis, Missouri), 137 mM NaCl (Sigma-Aldrich, S3014), 10% glycerol (G5516, SigmaAldrich), 1% Nonidet P40 (18896, Sigma-Aldrich), and 2-mM ethylene diamine tetraacetic acid (E6758, Sigma-Aldrich). Protein concentration was determined by Bradford protein assay, and 25 μg of protein was resolved on a 10% sodium dodecyl sulfate-polyacrylamide gel electrophoresis and transferred to a nitrocellulose membrane (Hybond; RPN3032D, Amersham Biosciences, Buckinghamshire, United Kingdom). The blotted membrane was blocked for 1 hour at room temperature in trishydroxymethylaminomethane-buffered saline (TBS) pH 7.4/Tween 0.1% (P9416, Sigma-Aldrich) containing 5% (wt/vol) bovine serum albumin (BSA; A9418, Sigma-Aldrich). All primary antibody incubations were performed overnight at 4°C in TBS-Tween 0.1% containing 5% BSA (wt/vol). The incubation steps were followed by 3 washing steps of 5 minutes with TBS containing 0.1% Tween. All primary antibodies were purchased from New England Biolabs (Cambridge, United Kingdom) and used at a dilution of 1:1000 as per the manufacturer's instructions. Specific primary antibodies used for primary human LEC included the following:
Binding of specific mitochondrial antibody was detected with a horseradish peroxidase-conjugated anti-rabbit IgG at a dilution of 1:2000 for 1 hour (A8792, Sigma-Aldrich). Primary antibodies used for mouse liver lysates included the following:
ATG7 (8558). 2. LC3B (3868). 3. p62 (5114).
Protein bands were visualized using the enhanced chemiluminescence detection system (RPN2109, Amersham Biosciences, Cambridge, United Kingdom) followed by exposure of the membranes to Hyperfilmenhanced chemiluminescence (28-9068-37, Amersham Biosciences). Equality of protein loading was checked by immunoblotting for β-actin (dilution 1:20,000; A2228, Sigma-Aldrich). All Western immunoblots were performed at least 3 times. Protein levels were quantified using densitometric scanning and normalized to loading control levels. Some samples required prolonged exposure of immunoblots for up to 48 hours at -4°C.
in vivO MODel OF partial liver iri
All animal experiments were performed at the University Medical Centre Groningen (UMCG), Groningen, the Netherlands, in compliance with the guidelines of the local animal ethics committee according to Experiments on Animals Act (1996) issued by the Ministry of Public Health, Welfare and Sports of the Netherlands. Wild-type C57BL/6 mice were anesthetized with isofluorane inhalation. Following laparotomy, an atraumatic clip was placed across the portal vein, hepatic artery, and bile duct just above the branching to the right lateral lobe. The median and left lateral lobes (approximately 70% of the murine liver mass) rapidly showed significant blanching. Following satisfactory clamp placement, the intestines were placed back into the abdominal cavity carefully and the incision was covered with well-moistened gauze with saline. The ischemic time used for the experiments was 90 minutes, and reperfusion time was 6 hours. The animals were then placed into heated chambers with free access to chow and free water. Sham-operated animals were handled in exactly the same manner other than undergoing clamping of the portal triad. Immediately following the reperfusion period, animals were again anaesthetised with isoflurane. The laparotomy wound was opened, 10 L of heparinized saline was injected directly into the inferior vena cava, and then venous blood was collected into a microsyringe. The animal was then killed by exsanguination, and the liver was removed. Original article | 1441 serUM preparatiOn anD QUantiFicatiOn OF liver transaMinase levels Serum levels of alanine aminotransferase (ALT) and aspartate aminotransferase (AST) were quantitative indices of liver damage used to assess liver injury and could be quantified in serum obtained from mice subjected to liver IRI. The samples were processed and quantified at the UMCG clinical chemistry laboratory using standard operating protocols. Data are presented as U/L at 37°C.
terMinal DeOXYnUcleOtiDYl transFerase-MeDiateD DeOXYUriDine triphOsphate nicK-enD laBeling assaY
A terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick-end labeling (TUNEL) assay was performed on mouse liver sections according to the manufacturer's instructions (Roche, Cambridge, United Kingdom). Samples were air-dried for 30 minutes at RT and washed 3 times with PBS for 3 minutes each. The sections were prefixed with 1% paraformaldehyde for 10 minutes at RT and then postfixed by precooled ethanol/acetic acid (2:1) at -20°C for 5 minutes. The fixed tissue sections were incubated with DAPI for nuclei staining following exposure to the equilibration buffer for 10 seconds at RT and terminal deoxynucleotidyl transferase enzymes for 30 minutes at 37°C. Images were captured with a CCD camera and imported into Adobe Photoshop. The quantification of TUNEL-positive LEC was performed by manually counting the number of TUNEL-positive LEC cells per randomly selected 10 high-power fields (HPFs) within sections in a blinded fashion by GMR.
histOpathOlOgY, iMMUnOhistOcheMistrY, anD iMMUnOFlUOrescence
Following exsanguinations, representative pieces of ischemic or noninjured liver lobes were quickly removed and fixed in ice-cold 10% phosphate-buffered formalin for 24 hours at 4°C. The tissue was then partially dehydrated with ethanol and embedded in JB4 plastic mounting media using standard histological methods. The 5-µm sections were cut and stained with hematoxylin-eosin (H & E). Immunoperoxidase staining for LC3B (rabbit monoclonal antibody, clone 5F10, New England Biolabs) and CD31 (goat polyclonal antibody, R&D Systems) were performed on the formalin-fixed, paraffin-embedded (FFPE) mouse liver tissue. Tissue sections were deparaffinized followed by antigen retrieval. Antibodies were incubated at room temperature for 1 hour at LCB (1:400 dilution) and CD31 (1:100 dilution). Antibody staining was developed using the IMMPACT DAB detection system (Ventana Medical Systems, Oro Valley, AZ) and accompanied by H & E counterstaining. Immunohistochemical staining was determined by quantifying the total area stained per randomly selected 10 HPF per section using ImageJ software.
For dual immunofluorescence, tissue sections were deparaffinized followed by antigen retrieval. After washing in TBS-Tween 0.1%, sections were incubated with LC3B antibody (1:400) for 1 hour at room temperature followed by incubation with IgG Alexa Fluor 594 donkey anti-human secondary antibody. Sections were washed with TBS-Tween 0.1% and incubated at room temperature for 1 hour with mouse anti-human CD31 antibodies (1:100, Abcam). After rinsing with PBS, sections were incubated with goat anti-human IgG Alexa Fluor 488 secondary antibody (1:2000; Molecular Probes) for 1 hour at room temperature. Sections were mounted with Anti-Fade mountant (Molecular Probes), and images were captured with a CCD camera and imported into Adobe Photoshop. Immunofluorescence staining was determined by quantifying staining intensity relative to control using ImageJ software.
statistical analYsis
All data are expressed as mean ± standard error of the mean (SEM). Statistical comparisons between groups were analyzed by Student t test. All differences were considered statistically significant at a value of P < 0.05.
Results
hUMan lec Maintain intracellUlar rOs thrOUghOUt iri that is inhiBiteD BY the general antiOXiDant nac
Isolated primary human LEC were exposed to our established in vitro model of IRI, (6, 8) and intracellular ROS were assessed using DCF as described previously. During Fig. 1A.   liver transplantatiOn, vol. 24, no. 10, 2018 BhOgal et al.
Original article | 1443 normoxia, LEC demonstrate high ROS content and exposure to hypoxia and then H-R does not significantly alter intracellular ROS content (Fig. 1) . Furthermore, primary human LEC isolated from different liver diseases such as alcoholic liver disease, biliary cirrhosis, and steatotic liver disease show similar intracellular ROS profiles during in vitro IRI (data not shown).
The general antioxidant NAC is able to efficiently inhibit ROS production within cells generated from a variety of sources including the mitochondria and cytosolic enzymes. (6) Incubation of primary human LEC with NAC significantly reduces intracellular ROS content during normoxia, hypoxia, and H-R with maximal effects noted with 6 hours of NAC treatment in each experimental condition (Fig. 2) . Taken together these data demonstrate that primary human LEC maintain high intracellular ROS levels during in vitro IRI that can be inhibited by NAC. Fig. 2 . NAC induces a time-dependent decrease in intracellular ROS in primary human LEC during in vitro IRI. Isolated primary human LEC were exposed to normoxia, hypoxia, or H-R in the presence or absence of the general antioxidant NAC. Representative flow cytometry plots illustrate the effect of NAC on primary human LEC intracellular ROS content during normoxia, hypoxia, and H-R. FS versus SS plots of primary human LEC are the same as those illustrated in Fig. 1A (data not shown) . The bar chart adjacent to the plots demonstrates the pooled data of 4 separate experiments and illustrates the effects of NAC upon human LEC ROS content during each of the 3 experimental conditions. Data are expressed as MFI, and readings are based on values taken from cells within the gated region shown in Fig. 1A . Data are expressed as mean ± SEM (*P < 0.05). intracellUlar rOs regUlates atg7 activitY, aUtOphagic FlUX, anD lc3B-pOsitive pUncta in priMarY hUMan lec DUring iri ROS has been previously linked to autophagy activation. (13) In primary human LEC, NAC-mediated ROS inhibition led to a specific reduction in ATG7 activity during in vitro IRI during normoxia, hypoxia, and H-R (Fig. 3 ) with no effect noted on ATG5, Beclin-1, or ATG12 (data not shown). In the canonical autophagy signaling pathway, ATG7 activation is upstream LC3B lipidation and autophagosome formation. (10) The formation of autophagosomes can be investigated by assessing the ratio of LC3B:p62 deriving Following normoxia, hypoxia, and H-R, primary human LEC were lysed and expression of ATG7, LC3B, and p62 was assessed by Western blotting as described in the Materials and Methods section. LEC were incubated with NAC for the stated times in either normoxia, hypoxia, or H-R. All Western blots were performed at least 3 times, and presented blots are representative of all samples (n = 3). (B) Blots were then analyzed using denisometric analysis and values normalized to β-actin loading controls (n = 3). Data are expressed as mean ± SEM (*P < 0.05; **P < 0.01; ***P < 0.001).
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an assessment of autophagic flux. NAC reduced autophagic flux during in vitro IRI as demonstrated by the reduction in LC3B protein and increase in p62 protein during normoxia, hypoxia, and H-R (Fig. 3) . These findings suggest that ROS specifically regulates ATG7 activity in human LEC during IRI, the inhibition of which leads to a reduction in autophagic flux in primary human LEC.
To further assess autophagy flux in human LEC, we used specific siRNA knockdown of ATG7 in LEC. As demonstrated in Fig. 4 , siRNA knockdown decreased ATG7 expression by approximately 60% in primary human LEC. Moreover, ATG7 knockdown inhibits autophagic flux as demonstrated by the decrease in LC3B and accumulation of p62 in human LEC during normoxia, hypoxia, and H-R. The inhibition of ATG7 activity in primary human LEC sensitizes cells to necrosis and not apoptosis (data not shown) during normoxia, hypoxia, and H-R suggesting that ATG7 function is integral to LEC survival during IRI.
ROS-dependent ATG7 activation also affects tempro-spatial LC3B-positive puncta in LEC during IRI as demonstrated by the loss of LC3B-positive puncta throughout the cytoplasm after NAC treatment (Fig. 5 ). Importantly this phenomenon was noted in normoxia, hypoxia, and H-R. Taken together these findings shown that ROS-dependent ATG7 activity mediates autophagic flux and autophagosome formation in primary human LEC during IRI.
rOs MeDiate MitOphagY in hUMan lec DUring iri
Recent studies have suggested that selective forms of autophagy occur within specific disease processes. (10) It is well established that during liver IRI dysfunctional mitochondria contribute to parenchymal cell injury. (19) Indeed the selective elimination of dysfunctional mitochondria, known as mitophagy, has recently been linked to progression of liver IRI. (9) We assessed whether LC3B-positive puncta are found in proximity to mitochondria in primary human LEC during IRI. To investigate this, we used the specific mitochondrial marker TOMM-20. Indeed, TOMM-20 and LC3B colocalize within human LEC during IRI (Fig. 6) . Importantly, inhibition of ROS with NAC for 6 hours caused a significant reduction in TOMM-20 and LC3B dual positivity suggesting that ROS-dependent ATG7 is a key regulator of mitophagy in primary human LEC during IRI.
rOs inhiBitiOn sensitiZes hUMan lec tO necrOsis DUring iri
The given data demonstrate that ROS activate autophagy/mitophagy in primary human LEC, and therefore, it would be expected that inhibition of ROS would induce cell death if autophagy/mitophagy were a cytoprotective mechanism in LEC as suggested in Fig. 4 with ATG7 knockdown sensitizing LEC to necrosis. Accordingly, we found NAC-mediated ROS-ATG7 inhibition increased human LEC necrosis during IRI (Fig. 7) . Maximal effects were noted during H-R after 6 hours of NAC treatment. Importantly, ROS inhibition sensitized primary human LEC to necrosis and not apoptosis (data not shown).
Fig. 4.
The siRNA ATG7 knockdown in human LEC does not affect intracellular ROS production but does alter autophagic flux and sensitizes human LEC to necrosis. (A) Lipofectamine-based transfection of primary human LEC with ATG7 siRNA led to a 60% knockdown in expression as verified by PCR expression of ATG7 mRNA. Following 24 hours of normoxia, hypoxia, and H-R, primary human LEC were lysed and expression of ATG7, LC3B, and p62 was assessed by Western blotting as described in the Materials and Methods section. All Western blots were performed at least 3 times, and presented blots are representative of all samples (n = 3). Blots were then analyzed using denisometric analysis and values normalized to β-actin loading controls (n = 3). Data are expressed as mean ± SEM (*P < 0.05).
Fig. 5.
Intracellular ROS regulates LC3B-positive puncta in primary human LEC during IRI. (A) Primary human LEC were exposed to normoxia, hypoxia, and H-R in the presence and absence of NAC. Following the desired incubation period, LEC were fixed and permeabilized. LC3B-positive puncta within LEC were assessed using immunofluorescence, and representative images are shown (n = 3). (B) LC3B-positive puncta in LEC were quantified using image analysis. NAC significantly reduces LC3B-positive puncta in primary human LEC during normoxia, hypoxia, and H-R. Data are expressed as mean ± SEM (*P < 0.01; n = 3). liver transplantatiOn, vol. 24, no. 10, 2018 BhOgal et al.
Original article | 1447 Primary human LEC were exposed to normoxia, hypoxia, and H-R for 6 hours in the presence and absence of NAC. Cells were fixed and permeabilized, and LEC expression for LC3B (red) and TOMM-20 (green) was assessed using immunofluorescence. DAPI was used for nuclear staining, and composite overlay images are shown on the right. Experiments were performed at least 3 times, and representative images are shown (n = 3). (B) LC3B-positive puncta and TOMM-20 staining in LEC were quantified using image analysis. NAC significantly reduces dual LC3B/ TOMM-20-positive puncta in primary human LEC during normoxia, hypoxia, and H-R. Data are expressed as mean ± SEM (*P < 0.01; n = 3).
reDUceD eXpressiOn OF lc3B in lec is assOciateD With liver iri in vivO
Our in vitro data suggest that ROS-ATG7-mitophagy is an important mechanism for survival of LEC during IRI. We used a murine model of partial murine liver IRI to investigate this relationship in vivo. As Fig. 8 demonstrates, partial liver IRI increases serum ALT and AST levels relative to sham-operated mice, and H & E liver sections demonstrate that the ischemic injury in IRI liver lobes was observed within the perivenular region of the liver with sparing of the periportal areas. In accordance with the in vitro data, sham-operated mice, and nonischemic/non-IRI liver lobes demonstrated sinusoidal staining with the specific autophagy marker LC3B (Fig. 8B ). This sinusoidal staining was also evident in murine liver tissue from sham-operated mice and demonstrated similar immunostaining to that seen with the specific LEC marker CD31. In the IRI liver lobes, we observed that both LC3B and CD31 staining is significantly reduced following injury (Fig. 8D) . Using dual immunofluorescence, we demonstrated that LC3B colocalizes with CD31 in noninjured and sham-operated livers (Fig. 8C) . Following IRI, the perivenular liver sinusoids demonstrated no LC3B or CD31 staining but did demonstrate TUNEL-positive cells in the sinusoids (Fig.  8G) , confirming the onset of apoptosis. Furthermore, similar to our observations in vitro, we observed that in noninjured livers ATG7 activity was present with active autophagic flux that is significantly reduced following liver IRI (Fig. 8D,H) . Taken together, this observation supports the observation that ATG7-mediated autophagy activation is associated with LEC survival during liver IRI.
Discussion
Liver IRI remains a significant clinical problem following liver transplantation with the injury targeting the liver parenchymal cells. LEC are the first cell type in the liver to be injured by IRI. (5, 20, 21) ROS generation is a key regulator of liver IRI and was until recently viewed as the primary driver for parenchymal cell death during IRI, (22) but more recent studies demonstrate that ROS is cytoprotective through Original article | 1449 its activation of the cellular process of autophagy. (8) Indeed, autophagy activation has been shown to limit injury following a variety of acute liver injuries, (23) (24) (25) and its role in regulating liver IRI is attracting growing attention. (11) Limited studies have explored the role of ROS-dependent autophagy during IRI, (26, 27) but the relationship between ROS and autophagy in LEC during IRI is not known.
Although the generation of low amounts of ROS is essential for normal cellular function, excess production of ROS is thought to cause cell death. (28) The classical cellular response to IRI is an increase in ROS . (E) Whole murine liver lysates were assessed for ATG7, LC3B, and p62 expression, and representative blots are shown. All Western blots were performed at least 3 times (n = 3). (F) The relative intensity of LC3B and CD31 immunofluorescence for the data presented in Fig. 8D (n = 5-7) . Data are expressed as mean ± SEM (*P < 0.05). (G) Demonstrates the number of TUNEL-positive LEC in liver sections following sham operations, noninjured liver lobes, and liver IRI lobes (n = 5-7). Data are expressed as mean ± SEM (*P < 0.05). (H) Shows the denisometric analysis of whole liver lysates analyzed for LC3B, ATG7, and p62. Values have been normalized to β-actin loading controls (n = 3). Data are expressed as mean ± SEM (*P < 0.05).
generation during hypoxia that is further accentuated during reperfusion. (6) Importantly, our in vitro model of liver IRI involves the manipulation of oxygen tension and does not recapitulate the other features of IRI such as glucose deprivation. Previous work from our group has shown that intracellular ROS generated in primary human hepatocytes activates autophagy to promote cell survival during IRI. (8) We now demonstrate that primary human LEC do not demonstrate this classical response to IRI (18) as they exhibit high levels of intracellular ROS levels that remain unaltered during in vitro IRI. Moreover, ROS does not induce cell death during IRI but instead is linked to ATG7 activity that can then regulate the downstream autophagy machinery as demonstrated by the formation of LC3B-positive puncta and protein analysis consistent with autophagic flux. (29) Although ROS-dependent ATG7 activation of autophagy has been reported in other endothelial cell types, (30) (31) (32) (33) (34) this is the first study to demonstrate this function of autophagy in primary human LEC. Importantly in vascular endothelial cells, the ROS-autophagy signaling pathway induces endothelial damage, (35) which highlights that autophagy may function differently in cells of different endothelial lineage. Interestingly, even in normoxic conditions, autophagic puncta are present within primary human LEC that may reflect the inherent scavenging function that LEC perform within the liver. The critical role of ROS-dependent autophagy activation in LEC is demonstrated by the inhibition of ROS in primary human LEC sensitizing cells to necrosis. These data are further corroborated by the selective knockdown of ATG7, also sensitizing LEC to necrosis. Importantly, our study used DCF to study ROS generation that specifically detects H 2 O 2 . The role of other ROS subspecies, such as mitochondrial ROS, superoxide (O2 -), and hydroxyl radicals (OH·) in regulating LEC autophagy remains to be determined. (36) It is important to recognize that although our in vitro model recapitulates many of the features of IRI, it does not include the restoration of flow during reperfusion and, in particular, omits the shear stress and biomechanical alterations that are integral to in vivo IRI. These factors may significantly change the autophagic response in LEC during IRI.
The in vitro data presented in this study suggest that autophagy in primary human LEC involves the selective elimination of dysfunctional mitochondria through the process of mitophagy. Recent studies have demonstrated that specific mitochondrial receptors such as FUNDC1 regulate mitophagy during hypoxia and ensure the timely elimination of dysfunctional mitochondria prior to mitochondrial depolarization (37) and cell death (38) as seen in other acute liver injuries. (39) Taken together, our study suggests that ROS-dependent mitophagy activation promotes LEC survival. However, ROS may also promote LEC survival through activation of autophagy-independent pathways. (40, 41) In addition, autophagy activation in other liver cells may also play a regulatory role during IRI, (8) and the relationship between LEC autophagy and these other cells remains to be determined. Moreover, inflammatory signals such as soluble tumor necrosis factor α and cell bound ligands upon inflammatory cells are integral features of liver IRI (4) and may alter LEC autophagy impacting upon LEC survival. Finally, although our isolation technique isolates LEC from liver tissue, the technique may also harvest vascular endothelium cells as well as liver sinusoidal endothelial cells, and thus, our cells represent a heterogeneous population of LEC.
Our in vitro data strongly suggest that autophagy/ mitophagy regulates LEC survival during IRI and to assess this mechanism in vivo we used a murine model of partial liver IRI. Immunohistochemical analysis of murine livers demonstrated that LC3B-positive staining was seen in liver sinusoids within uninjured liver lobes, which corresponded to the LEC marker CD31. Dual immunofluorescence confirmed that CD31 and LC3B colocalize within normal livers. Following IRI, there is centrilobular necrosis with the loss of both LC3B and CD31 immunostaining with concomitant impairment of autophagic flux as demonstrated with Western blotting showing the loss of LC3B and accumulation of p62. Recent studies have suggested that autophagy in LEC is regulated by KLF2 through a Rac1-rab7 pathway. (12) These studies suggest that failure to reactivate autophagy during reperfusion by activating KLF2 may regulate the increased cell death in LEC and is associated with microvascular dysfunction. (12) It remains to be determined whether KLF2 activation is ROSdependent in LEC or whether alternative signaling pathways such as transcription factor EB, (42) adenosine monophosphate-activated protein kinase, (43) hypoxia inducible factor 1, (44) and FOXO (45) can also regulate LEC autophagy. Overall, our findings suggest that the early injury to LEC during IRI is linked to a disruption in the autophagy-signaling pathway. (25, 46) Our finding that NAC causes autophagy inhibition and leads to LEC necrosis during IRI has important clinical implications. It suggests that general antioxidants targeted to the liver may not be an effective intervention to reduce IRI because although it may aid hepatocyte survival, (6) it will induce LEC death and potentially exacerbate the proinflammatory liver microenvironment. (47) In summary, our study demonstrates that in primary human LEC ROS-ATG7-dependent autophagy/ mitophagy promotes LEC survival during liver IRI, suggesting that targeting this signaling pathway in LEC during liver IRI may be an effective therapeutic strategy to reduce liver injury following surgery.
